Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $5.2 million.

  • Metagenomi's Other Non-Current Assets changed 0.0% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.2 million for FY2024, which is 444.28% down from last year.
  • According to the latest figures from Q3 2025, Metagenomi's Other Non-Current Assets is $5.2 million, which was down 0.0% from $5.2 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Other Non-Current Assets ranged from a high of $6.1 million in Q1 2023 and a low of $5.2 million during Q2 2023
  • Over the past 3 years, Metagenomi's median Other Non-Current Assets value was $5.2 million (recorded in 2023), while the average stood at $5.3 million.
  • Within the past 5 years, the most significant YoY rise in Metagenomi's Other Non-Current Assets was 0.0% (2024), while the steepest drop was 1358.47% (2024).
  • Quarter analysis of 3 years shows Metagenomi's Other Non-Current Assets stood at $5.5 million in 2023, then dropped by 4.44% to $5.2 million in 2024, then changed by 0.0% to $5.2 million in 2025.
  • Its last three reported values are $5.2 million in Q3 2025, $5.2 million for Q2 2025, and $5.2 million during Q1 2025.